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Abstract 33 
Detection and accurate quantitation of viable Mycobacterium tuberculosis is 34 
fundamental to understanding mycobacterial pathogenicity, tuberculosis (TB) disease 35 
progression and outcomes; TB transmission; drug action, efficacy and drug resistance. 36 
Despite this importance, methods for determining numbers of viable bacilli are 37 
limited in accuracy and precision owing to inherent characteristics of mycobacterial 38 
cell biology – including the tendency to clump, and “differential” culturability – and 39 
technical challenges consequent on handling an infectious pathogen under biosafe 40 
conditions. We developed an absolute counting method for mycobacteria in liquid 41 
cultures using a bench-top flow cytometer, and the low-cost fluorescent dyes Calcein-42 
AM (CA) and SYBR-gold (SG). During exponential growth CA+ cell counts are 43 
highly correlated with CFU counts and can be used as a real-time alternative to 44 
simplify the accurate standardisation of inocula for experiments. In contrast to CFU 45 
counting, this method can detect and enumerate cell aggregates in samples, which we 46 
show are a potential source of variance and bias when using established methods.  We 47 
show that CFUs comprise a sub-population of intact, metabolically active 48 
mycobacterial cells in liquid cultures, with CFU-proportion varying by growth 49 
conditions. A pharmacodynamic application of the flow cytometry method, exploring 50 
kinetics of fluorescent probe defined subpopulations compared to CFU is 51 
demonstrated. Flow cytometry derived Mycobacterium bovis BCG time-kill curves 52 
differ for rifampicin and kanamycin versus isoniazid and ethambutol, as do the 53 
relative dynamics of discrete morphologically-distinct subpopulations of bacilli 54 
revealed by this high-throughput single-cell technique.   55 
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Introduction 56 
For more than 100 years, counting Colony Forming Units (CFU) has been the gold-57 
standard for quantifying viable Mycobacterium tuberculosis (Mtb) bacilli, both in 58 
vitro and ex vivo. However, despite being a methodological foundation underpinning 59 
our scientific knowledge of Mtb, CFU counting has several technical and practical 60 
limitations, including cost and biosafety implications of maintaining multiple 61 
secondary cultures, time interval to results, loss of results from contamination, the 62 
inability to distinguish single cells from cell aggregates (clumps), and high intra- and 63 
inter-laboratory variation.1-3 64 
More fundamentally, under some conditions sub-populations of viable Mtb cells do 65 
not form colonies and are therefore unobserved by CFU counting.4-6 This is of 66 
particular relevance to tuberculosis (TB) diagnostics and research because of the 67 
prevailing theory that the existence of phenotypically heterogenous sub-populations 68 
of bacilli – with differential metabolic or growth states – underlie profound aspects of 69 
TB disease biology, such as latency and the need for prolonged therapy to effect 70 
sterilising cure.7-10 71 
Improved methods for absolute counting of mycobacteria and phenotypic 72 
characterisation of subpopulations are therefore desirable. Flow cytometry (FCM)73 
  is a well-established technique for counting and characterising eukaryotic 74 
cells, and its potential to advance single-cell analyses in microbiology has been 75 
discussed in depth.11,12 Several groups have applied FCM to mycobacteria, including 76 
drug sensitivity testing,13-22 investigation of cell biology,23-28 early phase diagnostic 77 
test development,29,30 live/dead discrimination,31,32 and more advanced single-cell 78 
phenotyping.23,33,34 Fluorescent dyes used by prior investigators include: probes of 79 
membrane integrity (the nucleic acid stains SYTOX-green,33 SYTO-9,24,31,32 SYTO-80 
BC,24,32 SYTO-16,16,28 SYBR-green I,30 propidium iodide,16,24,31,32,35 TO-PRO-3 81 
iodide,34 and auramine-O13,35,36); probes of metabolic activity (esterase substrate dyes 82 
fluorescein diacetate,14,17,20,21,37 and Calcein-violet33) and membrane potential 83 
(diethyloxacarbocyanine iodide25,34 & rhodamine-12327). In general, absolute bacillary 84 
counts have not been derived from FCM; instead, batch measures of fluorescence 85 
(e.g. mean fluorescence signal),13-17,20,21,27,29,37 qualitative read-outs (e.g. scatter-86 
plots),18,26,34 or percentages23,25,33 are reported. Growth conditions, processing (e.g. 87 
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washes and fixation), and staining protocols vary widely. In the few cases in which 88 
the same stains have been used by different groups, results are often contradictory: for 89 
example, propidium iodide is reported to stain 0% of heat killed M. tuberculosis by 90 
one study,38 and 100% by another.31 No comparisons of FCM counts with CFU 91 
enumerations have been published. 92 
The aims of the current study were: 93 
1) To develop and validate a method for absolute counting of mycobacteria in vitro 94 
using FCM. 95 
2) To explore the use of fluorescent dyes as probes of cell function to define 96 
subpopulations of bacilli in discrete physiological states. 97 
3) To compare dynamics of FCM-defined subpopulations and CFU in liquid cultures 98 
over time (growth curves), and over time in the presence of antimycobacterial 99 
compounds (time-kill curves). 100 
We report a method developed on a low-cost flow cytometer (BD AccuriTM C6), 101 
using two commercially available fluorescent dyes (SYBR®-Gold and Calcein-AM). 102 
The BD Accuri C6 flow cytometer has fixed alignment and pre-optimised detector 103 
settings, can record volume of sample processed without use of counting beads, and is 104 
small enough to fit on a benchtop or inside a bio-containment hood. SYBR®-Gold 105 
(SG), a proprietary cyanine dye (excitation ~495nm, emission ~573nm) with >1000-106 
fold fluorescence enhancement when bound to nucleic acid, was designed for use in 107 
gel electrophoresis.39 SG has previously been shown to have substantially greater 108 
sensitivity than auramine-O for quantitative fluorescence microscopy of heat-fixed 109 
mycobacteria (99% versus 65-80%),40 but it has not been applied in FCM. Calcein-110 
AM (CA) is a non-polar, lipophilic ester which becomes charged and fluorescent 111 
when hydrolysed by ‘house-keeping’ esterases ubiquitous in the cytoplasm of living 112 
cells.41 Hendon-Dunn and colleagues previously showed that the fluorescence of 113 
mycobacteria stained with Calcein-violet-AM correlated with rate of growth in a 114 
chemostat and declined with antimicrobial killing of bacilli.33  115 
In the present study, we applied SG staining after heat killing bacilli to define a total 116 
intact cell count denominator; SG staining without heat killing to probe cell 117 
membrane integrity as a marker of death or damage; and CA staining without heat 118 
killing to probe metabolic activity as a marker of vitality.  119 
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Setting fluorescence threshold values for FCM events improves validity 122 
of absolute bacilli counts  123 
The BD Accuri C6 flow cytometer has a fixed dynamic range for voltage and gain, 124 
but allows thresholds to be set on two signal values from light scatter and/or 125 
fluorescence channels. Signals below the set threshold are not recorded as events. For 126 
absolute counting of cells, an optimal threshold is one that is not so high as to exclude 127 
true events (signals from cells), yet high enough that it excludes electronic noise and 128 
signal from debris (which can otherwise mask true events owing to the refractory 129 
period of photodetectors). Typically, thresholds are set on forward and/or side scatter 130 
of light (FSC and SSC), as this allows fluorescence-positive and -negative events to 131 
be recorded without biasing measurements from the fluorescence channels.  132 
We investigated different threshold strategies as follows. Mid-log phase M. bovis 133 
BCG cultures were analysed after 2-fold dilution in 0.15% v/v Tween80 PBS 134 
solution. These were compared to an identical preparation of cell-free 7H9 broth as a 135 
negative control. Permutations of threshold settings were screened. In each case a gate 136 
was set around an apparent discrete population of events visible on a log(SSC) by 137 
log(FSC) plot, with the gate set manually to minimise the ratio between negative 138 
control and the paired BCG sample event counts. The optimal ratio (false positive 139 
event count in cell free broth divided by the paired BCG culture count) was defined as 140 
the false discovery rate; therefore, threshold parameters which maximised the 141 
absolute count in the BCG broth gate and minimised the false discovery rate were 142 
sought.  143 
Optimal threshold values based on light scatter (FSC and SSC) were inconsistent 144 
across replicates and were never associated with false discovery rates less than 10%. 145 
By contrast, thresholding on SSC and fluorescence (FL1 533/30 nm) in heat-killed, 146 
SYBR-gold stained mid-log BCG consistently reduced the false discovery rate to 147 
<0.5%, at the same time increasing absolute cell counts by more than one logarithm 148 
compared with thresholding on light scatter alone on the same samples (figure 1). 149 
Further, this strategy reduced the coefficient of variation between technical replicates 150 
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to <5%, and gave near perfect linearity across serial dilutions of the same sample 151 
(R2>0.99) (figure 1). 152 
Clumping in mycobacterial broth cultures can be observed and 153 
quantified using FCM  154 
In all mycobacterial broth cultures tested – M. bovis BCG, M. tuberculosis, and M. 155 
smegmatis, a second population of events with higher FSC and SSC became evident 156 
from early log-phase onwards, developing into the dominant population in mid- or 157 
late log-phase (figure 2A). To investigate the nature of these distinct populations, 158 
events gated on the two light-scatter populations were sorted for downstream 159 
microscopy (figure 2 B&C). This analysis revealed that the higher light-scatter 160 
population was composed of clumped cells, despite the fact that all cultures were 161 
grown in detergent (Tween80, 0.1% to 0.25% v/v) under continuous agitation (150 to 162 
200 rpm), and notwithstanding the use of sonication prior to flow cytometry. 163 
Clumping is a major determinant of CFU count & can be controlled by 164 
needle emulsification, but not vortex, sonication or centrifugation 165 
Having established the ability to quantify mycobacterial clumping in broth cultures 166 
using FCM, we next tested the comparative efficacies of standard microbiological 167 
methods for clump dispersal. Vortex and sonication failed to disrupt the clumped 168 
population observed on FCM; by contrast, needle emulsification of the broth culture 169 
largely eliminated clumping (figure 3A). Disruption of clumps by needle 170 
emulsification increased the single-cell population seen on FCM, and therefore the 171 
CFU count, by more than 0.5 log (figure 3B). Larger clumps not disrupted even by 172 
needle-emulsification emerged in late-stage broth cultures (figure 4).  173 
A standard method for preparation of single-cell suspensions of mycobacteria is 174 
centrifugation, based on the premise that cell clumps are selectively pelleted by 175 
gravity, with single cells remaining in suspension. 42 However, using FCM we found 176 
that the ratio of clumps to single-cells was unaffected by centrifugation (figure 5).  177 
Growth dynamics of FCM-defined bacilli populations compared to CFU 178 
A FCM protocol for absolute counting of bacilli – incorporating SYBR-gold or 179 
Calcein-AM staining, needle-emulsification to disperse clumps, and thresholding on 180 
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fluorescence (summarised in figure 6) – was used to explore dynamics of M. bovis 181 
BCG growth in broth culture. We defined three FCM populations using this protocol: 182 
1. Calcein-AM-positive (CA+) – live sample stained with Calcein-AM, to give 183 
an esterase positive, or ‘metabolically active’, cell count. 184 
2. SYBR-gold-positive (SG+) – live sample stained with SYBR-gold, to count 185 
cells which have membranes permeable to SYBR-gold, implying membrane 186 
damage. 187 
3. Heat-killed ‘total cell count’ (HK) – sample incubated in water-bath at 60oC 188 
for 12 minutes to permeabilise cell-membranes, followed by SYBR-gold 189 
staining. This is proposed to give a total count of intact cells containing 190 
nucleic acid, and therefore provides a denominator for calculating the 191 
proportion of cells which are CA+, or  SG+, or colony-forming. The selected 192 
heat-kill time and temperature were selected as the minimum to reliably 193 
maximise the HK count. 194 
CFU counts after needle emulsification were determined in parallel (figure 6).  195 
In all culture growth phases (lag, log, stationary), the HK cell count was greater than 196 
CA+, SG+, or CFU counts (figure 7A), and was accepted as a total cell count. During 197 
log-phase, most cells were CA+ and colony forming, with SG+ cells constituting a 198 
minority sub-population (figure 7B-D). When entering stationary phase, CA+ and 199 
CFU counts started to fall, with a simultaneous rise in SG+ cells, which subsequently 200 
became the dominant subpopulation (figure 7B-D). 201 
Correlation between CFU and CA+ counts was growth-phase dependent (figure 7E) 202 
with close co-variance in early-to-mid-log phase progressively diminishing in late-log 203 
(when CFU > CA+) and stationary phase (when CA+ > CFU). Total population 204 
growth rate – defined using the instantaneous rate-of-change of the log HK total cell 205 
count (the slope of the tangent to the curve at a given timepoint, i.e. the first-206 
derivative) – correlated with the proportion of bacilli which were CA+, but not the 207 
proportion of bacilli forming colonies (figure 7F). 208 
In vitro pharmacodynamics of M. bovis BCG by CFU and FCM counting 209 
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Having established growth dynamics in the absence of antimicrobials, the FCM count 210 
method was applied to pharmacodynamic (PD) time-kill analysis of M. bovis BCG. 211 
Starter cultures (100 ml in 500ml tissue culture flasks containing 0.15% v/v Tween 80 212 
7H9 medium) were grown to a density of ~2x105 CA+ cells per ml, then split into 213 
20ml samples in 50ml conical flasks. Antimicrobials (rifampicin, isoniazid, 214 
kanamycin, ethambutol) were added at a range of final concentrations in multiples of 215 
their minimum inhibitory concentration (MIC99), and bacilli quantified at 0, 24, 48, 216 
72 and 120 hours using FCM and CFU counting. The experiment was repeated on 217 
three separate occasions to ensure independent biological replicates.  218 
Raw FCM data plots for heat-killed, Calcein-AM, and SYBR-gold stained 219 
preparations from one of three independent replicates are shown for selected 220 
conditions in figure 8A-C. Time-kill curves based on absolute counts, and proportions 221 
(CA+/HK, SG+/HK, CFU/HK counts), are shown in figures 9A & 9B, respectively.  222 
Compared to antimicrobial-free controls, total cell count (HK count) growth was 223 
generally impeded by the presence of antimicrobials, although exponential growth 224 
still occurred with ethambutol and kanamycin at 0.5xMIC concentration of both 225 
antimicrobials. Critically, even at high concentrations of all antimicrobials tested, HK 226 
count did not show dramatic reduction over 120 hours of exposure.  227 
By contrast, CA+ and CFU counts fell substantially over that time period. Notably, 228 
CFU counts declined earlier than CA+ counts for all antimicrobial tested for all 229 
inhibitory concentrations. Rifampicin or kanamycin exposure resulted in an earlier 230 
decline in CA+ counts than was observed for isoniazid or ethambutol, which at high 231 
concentrations showed an initial increase in proportion of cells CA+ at 24 hours, 232 
before a sustained fall to day 5. 233 
Because a fraction of cells were SG+ under any condition, the major driver of 234 
absolute SG+ count was the total cell count, this can be seen in the antimicrobial-free 235 
controls where the highest SG+ counts were seen at late stages of growth. The 236 
proportion SG+ was, however, antimicrobial dependent: SG+ cells were a majority by 237 
day 5 in all supra-MIC concentration conditions, but the rise in the SG+ proportion 238 
occurred earlier and was larger for isoniazid and ethambutol than for rifampicin or 239 
kanamycin.  240 
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To summarise differing effects by antimicrobial and subpopulation, sigmoidal Emax 241 
models were fitted to the time-kill data (figure 10). Based on CFU time-kill curves, 242 
rifampicin, kanamycin, and isoniazid all have similar Emax values, while ethambutol is 243 
substantially lower. CA+ time-kill Emax was higher for rifampicin and kanamycin; and 244 
lower for ethambutol and isoniazid. The pattern was reversed for the effect on SG+ 245 
proportion. Finally, while the effects of antimicrobials on total cell count (HK count) 246 
were modest, they did differ by antimicrobial, with Emax highest for rifampicin and 247 
lowest for ethambutol.  248 
Subpopulations of cells by SYBR-gold staining characteristics 249 
In addition to count data, qualitative differences in fluorescence were seen in live 250 
bacilli stained with SYBR-gold, with two subpopulations of SG+ cells separated by 251 
FL1 intensity (most distinct after 72 hours of isoniazid or ethambutol exposure, figure 252 
8C). We hypothesised that two populations of bacilli with different SG staining 253 
properties were revealed by the membrane permeabilising effects of these 254 
antimicrobials. To investigate this possibility, we developed a protocol for 255 
permeabilising M. bovis BCG membranes without bacillary destruction (detailed in 256 
methods), and characterised these subpopulations under different antimicrobial 257 
conditions by quantifying them and through direct microscopy after cell-sorting.  258 
Dual SG+ subpopulations were discriminated by distribution peaks (figure 11A) and 259 
were seen under all conditions, including growth without antimicrobial exposure 260 
(figure 11B) with one population (labelled P2) returning a mean fluorescence two-261 
fold higher than the other (labelled P1) (figure 11A&C).  Fluorescent microscopy of 262 
cell-sorted samples showed that, compared to P1, P2 bacilli were longer (mean 4.0μm 263 
versus 2.5μm), with double the number of fluorescent foci (mean 6.1 versus 3.2) 264 
(figure 11D). The ratio of P2 to P1 cells in antimicrobial-free cultures was median 265 
1.75, and non-significantly higher when bacilli were exposed to rifampicin or 266 
kanamycin (median 1.83 and 1.86, respectively), but significantly higher after 267 
exposure to ethambutol or isoniazid (median 2.11 and 2.00, respectively; p<0.001 for 268 
both by rank-sum test). The P2:P1 ratio when bacilli were incubated with both 269 
rifampicin and isoniazid matched rifampicin mono-exposure rather than isoniazid 270 
mono-exposure (figure 11E). 271 
 272 
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Discussion 273 
Detection and accurate quantitation of Mycobacterium tuberculosis is fundamental to 274 
understanding TB biology. Growing evidence suggests that culture-based methods 275 
detect only a sub-population of bacilli,4,5 yet these methods remain standard in 276 
mycobacterial sciences. By contrast, in response to the analogous problem of 277 
differential culturability of microbiota in environmental substrates, FCM has been 278 
adopted as an essential method in environmental microbiology research,60,61 and 279 
industry. 62,63 We developed a novel FCM-based method for absolute counting of 280 
mycobacteria in liquid cultures. While several groups have reported characterising 281 
mycobacteria using FCM, our method is the first to give absolute counts, and can be 282 
used to quantify total cell denominator, the presence of cell-clumps, and sub-283 
populations with metabolic activity (using the esterase substrate, Calcein-AM) or 284 
membrane permeability (using the nucleic acid stain, SYBR-gold). Our results 285 
highlight some critical shortcomings of current ‘gold-standard’ methods for 286 
mycobacteria quantification. We also illustrate how the FCM absolute count method 287 
can be used for high-throughput, rapid investigations of phenotypic heterogeneity in 288 
mycobacteria and demonstrate the capacity to extract pharmacodynamic data using 289 
this approach. 290 
Using our FCM method we found that we could reliably identify a subpopulation of 291 
the batch culture comprising clumped cells. Further investigations revealed that 292 
mycobacterial cultures remain prone to  cell clumping in spite of commonly used 293 
measures to reduce their formation and to disrupt these before experimentation. We 294 
found that sample processing has a major impact on clump-dispersal, such that needle 295 
emulsification could increase CFU count approximately two-fold even in early log-296 
phase growth. This implies the potential for significant noise and bias in CFU 297 
determination, especially for late-log and stationary phase cultures, given that the 298 
method depends on serial dilution of dispersed cultures. Our data suggest published 299 
protocols42 for producing single cell suspensions using centrifugation have no effect 300 
on the ratio of clumps to single cells. Using the needle-emulsification and FCM 301 
counting methods described would be expected to reduce experimental error in 302 
mycobacterial research where bacilli counts are needed to standardise starting 303 
conditions, or where the number of bacilli is the dependent variable of interest. 304 
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Further, under antimicrobial-free early-mid log-phase growth conditions, CA+ 305 
bacillary counts correlate well with CFU counts and can be obtained within 90 306 
minutes using low-cost reagents indicating that the FCM counting method is a 307 
practicable alternative to current culture-based methods of estimating cell numbers. 308 
Our FCM method is distinct from previously described mycobacterial FCM protocols 309 
primarily because a fluorescence threshold is used to determine when FCM events are 310 
recorded. This means that fluorescence-negative events (e.g. a Calcein negative cell) 311 
cannot be directly observed but permits accurate absolute counts to be reported for the 312 
first time in mycobacterial flow cytometry. Because an absolute cell count 313 
denominator can be established with SYBR-gold staining of heat-killed bacilli, the 314 
proportion of bacilli with a given characteristic can be ascertained. Importantly, a total 315 
cell denominator also allows the proportion of bacilli forming colonies to be 316 
measured, which was about 60% in mid-exponential phase of growth in liquid culture.  317 
Our pharmacodynamic results build on previous mycobacterial flow cytometry work 318 
reported by Hendon-Dunn et al.33 We replicate their finding that pharmacodynamic 319 
flow cytometry profiles based on fluorescent probes of cytoplasmic esterase 320 
metabolism and cell wall integrity are different for drugs with different mechanisms 321 
of action. We found that the cell wall acting drugs isoniazid and ethambutol were 322 
associated with a relatively rapid rise in SG+ cells, while the cytoplasmic targeting 323 
rifampicin and kanamycin showed relatively early decline in CA+ bacilli. However, 324 
Hendon-Dunn et al. observed only a moderate, concentration-independent effect of 325 
rifampicin on Calcein-violet positive bacilli over the first 4 days of exposure. By 326 
contrast we found that rifampicin had an early, concentration-dependent effect on 327 
CA+ cells, and this effect was substantially greater than for isoniazid. Hendon-Dunn 328 
et al. measured relative proportions of Calcein positive and negative cells in 329 
cytometry plots, while our method produces absolute cell counts. If antimicrobials 330 
have differential effects on the total cell count (which we observed), relative 331 
proportions could be unreliable readouts of drug effect (owing to a ‘denominator 332 
fallacy’). In addition, the manual gating strategy used by Hendon-Dunn et al. does not 333 
appear to capture the shift in mean Calcein fluorescence seen under early rifampicin 334 
action, whereas the unsupervised classification approach implemented in this method 335 
does.  336 
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Again, based on absolute counts, we were able to directly and quantitatively compare 337 
CFU and FCM sub-population pharmacodynamics. Under all antimicrobial conditions 338 
tested, elimination of colony forming bacilli occurred substantially earlier than the 339 
decline in CA+ bacilli or the rise in SG+ bacilli. This means that, at some time points 340 
a majority of bacilli are structurally intact with evidence of metabolic activity but do 341 
not form colonies.  Further, we show that pharmacodynamic effect estimates based on 342 
FCM-defined subpopulations give different read-outs from those based on CFU 343 
counts: the rifampicin effect on CFU elimination is similar to isoniazid, but rifampicin 344 
elimination of CA+ bacilli is markedly greater; rifampicin also has a larger effect on 345 
total cell count than the other antimicrobials tested. Rather than simply being a rapid 346 
surrogate for CFU counts, the FCM method therefore provides information on 347 
antimycobacterial drug pharmacodynamics not captured by CFU counting, but it is 348 
unknown if this information is clinically meaningful. Terminally injured bacilli may 349 
simply retain metabolic activity with residual enzyme activity in a non-viable cell. 350 
Alternatively, as non-growing metabolically active (NGMA) cells can be capable of 351 
resuscitation,55 this may represent an adaptive response to antimicrobial stress by 352 
reducing the physiological consequences of target inhibition.56 FCM probes of 353 
metabolic and structural integrity would then be more meaningful measures of 354 
viability. The latter would be a simple explanation for the lack of correlation between 355 
culture-based surrogate endpoints (early bactericidal activity measured using CFU 356 
counting, 2-month culture conversion, modelling serial CFU counts or time-to-357 
positivity in liquid culture) and probability of achieving sterilising cure in clinical 358 
tuberculosis pharmacodynamics43 and warrants testing in clinical samples.  359 
If NGMA bacilli are an adaptive response to antimicrobial exposure then the ability to 360 
characterise them using high-throughput methods is critical. By staining live but 361 
membrane-permeabilized bacilli with SYBR-gold, we observed two distinct bacilli 362 
sub-populations, separated by a two-fold difference in mean fluorescence. We found 363 
this phenotype-variation was specifically induced by exposure to isoniazid or 364 
ethambutol, but the isoniazid effect was inhibited by the presence of rifampicin. 365 
Importantly, the induction of this phenotype could be seen at antimicrobial-condition-366 
timepoints where >99.9% of CFU were already eliminated (e.g. after 72 hours of 367 
isoniazid exposure at 4x MIC concentration). After cell-sorting, bacilli from the two-368 
fold brighter subpopulation were found to be longer with double the number of 369 
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fluorescence foci. Given that SYBR-gold fluoresces when bound to nucleic acid, this 370 
implies a bacillary phenotype with double the nucleic acid content, and this 371 
phenotypic heterogeneity may therefore represent different numbers of chromosome 372 
copies. In a non-human primate model of tuberculosis, “chromosomal equivalents” 373 
remain abundant in granulomas that have been sterilised (rendered CFU-negative) by 374 
isoniazid therapy.64 Peaks separated by a 2-fold difference in fluorescent intensity 375 
after staining with ethidium bromide or PicoGreen have been used extensively to 376 
define multiple chromosome numbers in E. coli.44-46 Further, several groups have 377 
associated polyploidy in E. coli with elongated “filamentous” persister cells capable 378 
of accelerated antibiotic resistance evolution.46-48 In the Wayne model of non-379 
replicating persistence during hypoxia-induced stress, mycobacteria are found to be 380 
diploid.49 In an in vitro foamy-macrophage model, intracellular Mycobacterium avium 381 
has been shown to enter a reversible dormancy state where the bacilli elongate but do 382 
not divide (implying they would not form colonies);57 it is suspected that these 383 
elongated, metabolically-active but non-replicating mycobacteria may be polyploid.50 384 
We speculate that polyploid, metabolically-active but non-colony forming bacilli 385 
which are preferentially induced by isoniazid but not rifampicin may be of significant 386 
clinical interest. If they represent a drug-tolerant phenotype unobserved by CFU 387 
counting, this could explain the fact that, while isoniazid has the most potent early 388 
bactericidal activity (EBA, measured by CFU counting), only rifampicin-containing 389 
regimens can reliably effect sterilising cure after 6-months (“short-course”) therapy. 390 
That drug resistant mutants emerge from phenotypically drug tolerant cells has 391 
recently been described for clinical isolates of Staphylococcus aureus,58 a similar 392 
mechanism might exist for mycobacteria. The spontaneous drug resistance mutation 393 
rates for M. tuberculosis in vitro range from 10-7 to 10-9 and it is somewhat unclear if 394 
estimated total mycobacteria numbers in vivo allow for development of multidrug 395 
resistance through the simple product of these probabilities59 – particularly if drug 396 
resistance emerges de novo after EBA has eliminated most bacilli observable by 397 
culture. A population of bacilli, unobserved by CFU counting but capable of 398 
elongation and polyploidy, implies ongoing chromosome replication after 399 
antimicrobial exposure and a pool of drug-tolerant cells from which drug resistance 400 
could emerge.  401 
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We used batch cultures in this work which may have limitations. Unexplained 402 
variation in FCM sub-population proportions and growth rates between biological 403 
replicates, even under antimicrobial-free conditions were seen (e.g. figure 7 B&F). 404 
Steady-state cultures – such as the chemostat method used by Hendon-Dunn in their 405 
flow-cytometry study – are known to improve reproducibility compared to batch 406 
cultures in microbial proteomics and transcriptomics analyses,51,52 and are likely to be 407 
a major advantage in pharmacodynamic studies. Indeed, cell populations in batch 408 
cultures can show complex, non-linear growth patterns in cell size and DNA content44 409 
(which are major read-outs from the current implementation of our FCM absolute 410 
count method). However these limitations of batch cultures, match those of currently 411 
implemented culture methods in research laboratories and are expected to add noise 412 
rather than bias to our results.  413 
Overall, our results add to the evidence of limitations in established methods for 414 
enumeration of bacilli and support the utility of FCM as a high-throughput, single-415 
cell, culture-independent quantitative tool for the study of mycobacteria in preclinical 416 




Flow cytometry was performed on a BD Accuri™ C6 with manufacturer standard 421 
fluorescence detector set-up (FL1, 533/30 nm; FL2, 585/40 nm; FL3, > 670 nm; FL4, 422 
675/25 nm) and data acquisition with BD Accuri™ C6 software including recording 423 
processed sample volume. Quality assurance was performed using fluorescent beads 424 
as per manufacturer protocol. Manual and extended cleaning cycles were performed at 425 
the beginning and end of each flow cytometry session with verification of low event 426 
rate in filtered PBS before each run. Cell-sorting experiments were performed on a 427 
Bio Rad S3 cell sorter or FACS Vantage with voltage and gain set to recreate BD 428 
Accuri C6 plots. All microscopy was performed on a Zeiss Axio Observer 7.  429 
Sample processing 430 
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Needle emusfication was performed with 12 passes through a double luer-lock ended, 431 
25 Gauge, 4-inch, micro-emulsifying needle (CAD7974 Sigma Aldrich). Sonication 432 
of cultures prior to FCM to assess effect on clump dispersal was performed by 433 
submerging 1ml centrifuge tubes attached to a flotation device in a benchtop 434 
ultrasonication water-bath three times for 30 second duration (Ultrawave™ U300HD 435 
30 KHZ; Ultrawave, Cardiff, UK).  Heat-kill of mycobacterial samples for “HK 436 
counts” was by immersion of aliquots in a waterbath at 60oC for 12 minutes. Removal 437 
of antimicrobials prior to CFU plating was by pelleting a 1000μL sample (diluted 2-438 
fold from 500μL with PBS) at 18000g for 12 minutes, removing 900μL of 439 
supernatant, resuspending 100μL residual volume in 900μL of 0.22um filtered 0.15% 440 
v/v Tween 80 sterile PBS by pipetting, repeated twice (for 10x10 = 100-fold dilution). 441 
This will have diluted antimicrobial in solution (unbound) 200-fold prior to plating.  442 
Culture conditions 443 
Liquid media was prepared from Middlebrook 7H9 media (211887 BD Diagnostics) 444 
and 0.22um filtered deionized water according to manufacturer instructions. This was 445 
supplemented with 10% v/v Middlebrook OADC (212240 BD Diagnostics), 0.2% v/v 446 
glycerol and 0.15% v/v Tween 80. All broth was autoclaved prior to supplementation, 447 
and 0.22um filtered prior to use. Liquid cultures were at 37oC in the dark with 150-448 
200rpm agitation in 50ml sterile polyethylene conical flasks in an incubator with an 449 
orbital shaking system (model LM-570; MRC Laboratory Instruments Group, 450 
London, UK).  451 
Middlebrook 7H10 (262710 BD Diagnostics) agar was prepared with 0.22um filtered 452 
deionized water according to manufacturer instructions, with v/v 0.5% glycerol added 453 
before autoclave sterilisation. When cooled to 45oC, v/v 10% ADC supplement was 454 
added and tri-segmented plates poured to depth 5mm. For CFU counting, 10-fold 455 
serial dilutions of samples were prepared in 96-well plates using 0.22um filtered 456 
0.15% v/v Tween 80 sterile PBS. Each segment of a plate was inoculated with 50uL 457 
of serial dilutions and spread using disposable, sterile loop spreaders. CFU counts 458 
were performed with 3-fold technical replicates and counts averaged. Colony counts 459 
between 1 and 100 per segment were accepted and, after adjustment for dilution, 460 
averages across dilutions were made where available. Counts were performed on 3 461 
occasions (14, 21, and 28 days) to allow colonies to be counted before overgrowth. 462 
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Reagents 463 
Primary stock dilutions of antibiotic powders were made in 100% DMSO and frozen 464 
at-20oC protected from light. Fresh working dilutions were prepared in PBS prior to 465 
each experiment, 0.22nm filtered, and stored wrapped in tin foil at 2-5oC refrigeration. 466 
Final concentrations of antimicrobials used in M. bovis BCG time-kill experiments are 467 
reported in multiples of the MIC as indicated. The MIC were: rifampicin, 0.01μg/ml; 468 
isoniazid 0.125μg/ml; kanamycin 1.0μg/ml; ethambutol 1.0 μg/ml.  469 
Calcein-AM 50μg vials (ThermoFisher, C3100MP) were reconstituted in 50μL of 470 
DMSO on the day of each experiment, further diluted to 200μL with PBS for 471 
“working stock”. For cell staining, 5μL of working stock was added per 100μL of 472 
sample, with pipette mixing, then incubated in the dark at room temperature for 45-60 473 
minutes before resuspension of bacilli with pipetting. SYBR-gold propriety stock 474 
(ThermoFisher, S-11494) was diluted 1000-fold in PBS, aliquoted and frozen at -20oC 475 
until use. After thawing aliquot, a further 10-fold dilution (to 10-4) in PBS was 476 
performed, and 5μL of this working stock added per 100μL of sample to be stained, 477 
with pipette mixing, followed by incubation in dark at room temperature for 45-60 478 
minutes before resuspension of bacilli with pipetting. 479 
Permeabilization of live cells 480 
For the investigation of SG stained subpopulations, published methods for 481 
permeabilizing mycobacterial cell walls were reviewed; those with highest reported 482 
success and best description of validation53,54 were taken forward for testing and 483 
adaptation. Permutations of paraformaldehyde / ammonium chloride fixation, ethanol, 484 
hydrochloric acid, detergents, and lysozyme were tested at different concentrations, 485 
incubation times, and temperatures also assessed iteratively. This led to a final method 486 
for reliable permeabilization of BCG bacilli without substantial cell loss, such that 487 
over 80% of bacilli could be SYBR-gold stained (compared to the heat-killed total 488 
cell count denominator gold standard). In the final method, a 500μL sample was 489 
diluted to 1ml with PBS v/v 0.15%Tween 80, without wash step or fixation. After 490 
needle emulsification, lysozyme was added to final conc 0.1mg/ml, and the sample 491 
incubated for 45 minutes at 37oC. 500µl triton-X-100 was then added to final 492 
concentration v/v 0.2%. This was pelleted (16000g, 5 min) and re-suspended in 500µl 493 
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PBS-tween; 40µl working stock SYBR-gold added and incubated at room 494 
temperature for 2-4 hours. 495 
Data analysis 496 
Raw flow-cytometry data was extracted from .fcs files exported from BD Accuri C6 497 
software using flowCore (v 2.0.1) Bioconductor package65 and all analysis performed 498 
in Rstudio v1.1.463. Rather than using manually placed gates to classify events, 499 
unsupervised machine-learning classification algorithms were used. For main flow 500 
cytometry plots (figure 8) k-means clustering was applied to FL1 height, FL1 area, 501 
and Side-Scatter height observations from one replicate using kmeans() function in 502 
stats package66 in R, and the clustering solution applied to all the data. Optimal 503 
number of clusters was determined empirically using NbClust() function from 504 
NBClust package67 in R. To separate P2 and P1 events in permeabilized SG-stained 505 
live cells (figure 11), a Gaussian Mixture Model was fit to all the data with 2 506 
component distributions using normalmixEM() function in mixtools package.68 In all 507 
FCM scatter plots, log transformations to base e (natural logarithms) are presented 508 
unless otherwise indicated (plots with log transformations to base 2 are used in cases 509 
where a doubling of fluorescence is a specific feature of interest).  510 
Time-kill curves were summarised in descriptive plots (figure 9) using non-parametric 511 
loess regression models. To extract summary measures of antimicrobial effect, the 512 
time-kill data was modelled using a linear mixed-effects model, with a fixed effect of 513 
intercept, and random slopes for antibiotic condition and replicate: 514 
    ~   |   |  
This captures the crossed experimental design where each replicate was assessed 515 
under each antimicrobial condition, and each replicate assessed under each condition. 516 
The antibiotic condition effect, defined as slope gradient for the time-kill curve, was 517 
then extracted, independent of replicate effect, from the model as a summary PD 518 
measure. Because the dependent variable is on a log scale this assumes a mono-519 
exponential decline in cell populations under antimicrobial action. The dependent 520 
variables assessed were CFU count, CA+ count, HK count, and proportion SG+. The 521 
R package lme4 was used for this modelling.69  522 
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Antimicrobial effects extracted from these models were related to drug concentration 523 








Where E is the PD effect (the slope gradient estimates by mixed-effects modelling 525 
above), C is the drug concentration (known from experimental condition), and the 526 
remaining parameters are estimated from the data: Emax (maximum achievable effect 527 
of antimicrobial), EC50 (the drug concentration where half of Emax is obtained), and n 528 
(a scaling parameter). Models were fitted using non-linear least squares (nls() function 529 
in R.  530 
Fluorescence profiles of bacilli (figure 11D) were extracted as .csv files from 531 
microscopy images using Fiji (ImageJ).70 This raw data was processed using a 532 
custom-built function defining local maxima in smoothed profiles to count fluorescent 533 
peaks.  534 
  535 
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Figure 1. Comparison of 3 thresholding strategies in heat killed and SYBR-gold stained mid-log 




A. Example FCM plots for three thresholding strategies (rows 1-3) applied to M. bovis BCG broth culture (column
1) and cell-free broth (cell-free negative control, column 2). Counts are extracted for the gated population (events
within dashed red line), which is placed to maximise the count in BCG broth and minimise the count in the cell-free
control. Recorded events in the low light scatter value thresholding (first row) are dominated by debris/noise, seen as
a dense population with low SSC and FSC values in lower left quadrant; this is equally apparent in the cell-free
control. Higher light scatter thresholding (second row) excludes these events, but still records a substantial portion
of higher SSC/FSC noise (seen in cell-free control), and the threshold level appears to bisect the ‘real’ cell
population; i.e., losing cells from analysis. By contrast, the thresholding based on fluorescence (third row) is
qualitatively better, with very few false positive events in the cell-free control, and detection of a discrete cell
population in BCG broth which is not artificially bisected. 
B. Greater internal consistency in the FL1/SSC thresholding strategy, with less error across serial dilutions of a M. 
bovis BCG culture. Quantitative evidence of improved absolute count validity includes a lower false discovery rate 
(FDR, defined as false positive cell count in cell-free control divided by paired cell count from broth); lower 
coefficient of variation (CV, calculated by standard deviation/mean from 5 technical replicates, averaged for 3 
biological replicates); and higher R2 from linear fit across serial dilution series (one biological replicate as shown in 
figure; p<0.001 for F test comparing FL1/SCC to either FSC/SSC strategy; 95% confidence intervals for linear fit 
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Figure 2. Identifying mycobacterial clumping with FCM. 
 
 
A. 2D-density plots of FSC v SSC on log scale for a culture of M. bovis BCG grown with 0.15% v/v Tween80 at
180 rpm. Plots are from samples taken at 48, 96, 144, and 240 hours after bacilli were sub-cultured from a log-phase
starter culture into pre-warmed broth (early, early-mid, late-mid and late log-phase, respectively). Samples were
diluted 10-fold or 100-fold (later samples) in 0.25% v/v Tween80 PBS and sonicated for 60 seconds prior to flow
cytometry. The tail of higher SSC and FSC events at 48-hours is seen to develop into a discrete second
subpopulation by 96-hours, which continues to expand into a higher SSC and FSC region and become the
predominant subpopulation by the end of log-phase. All plots are constructed from 5000 events. 
B. M. tuberculosis and M. smegmatis processed as above (both mid-late log phase) also develop dual populations
separating on FSC and SSC, replicating the M. bovis BCG findings. 
C. M. smegmatis sample was run on a BioRad S3 cell sorter with P1 and P2 sorted for downstream fluorescence 
microscopy (representative images shown). M. smegmatis was used for cell sorting owing to concerns about 
aerosolising M. tuberculosis or M. bovis BCG. P1 comprised majority single cells or doublets, while P2 comprised 
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Figure 3. Needle-emulsification, but not vortex or sonication, disrupt clumps and increases cell 
counts 
 
Mid-log phase culture of M. smegmatis grown in 0.15% v/v Tween80 7H9 with 150 rpm agitation and diluted 10-
fold in 0.15% v/v Tween80 PBS and stained with Calcein-AM prior to FCM on a BD Accuri C6. Data acquisition
with thresholds SSC>1000 and FL1>2000. Samples were processed by 60 second vortex, or by 60 second vortex
followed by 5 minutes sonication in water bath, or by both these methods followed by needle emulsification (12
passes through a double Luer lock-ended, 25 Gauge, 4-inch, micro-emulsifying needle with a reinforcing bar
(Cadence Inc.). 
A. Two populations are seen which are differentiated by light-scatter: single cells (P1) and clumps (P2).
Qualitatively, vortex and sonication processing did not disrupt P2 population (clumps), but needle emulsification
(far right plot) shifted events from predominantly P2 (clumps) to predominantly P1 (single cells). 
B. Counts of CFUs or FCM events with three-replicates from 3 independent cultures (purple, green, yellow dots). 
Emulsification resulted in a greater number of CFU and decreased the P2 count while increasing the P1 count 
substantially. The apparent total cell counts were increased by emulsification by an order of magnitude: both CFU 
count and total flow cytometry CA positive count increased by half to one unit on log scale. This can be interpreted 
as resulting from clumps (P2 population) being disaggregated into single cells (P1). The p-values were determined 
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A. M. bovis BCG culture in 0.15% v/v Tween80 7H9 with 150 rpm agitation and diluted 10-fold in 0.15% v/v
Tween80 PBS before bacilli were heat-killed and stained with SYBR-gold. Samples were needle-emulsified (12
passes through a double Luer lock-ended, 25 Gauge, 4-inch, micro-emulsifying needle) prior to FCM on BD Accuri
C6; data acquisition with thresholds SSC>1000 and FL1>1000. Timepoints are days post inoculation into pre-
warmed broth from log phase starter culture. A long tail of clumps, extending into the upper-right quadrant of higher
SSC and FSC, emerges from around day 9, at OD600 ~ 0.3. Clumps were defined as events with SSC and FSC values
greater than 10-log and 11-log (events in upper right quadrant of plots). 
B. Clumps and single cells quantified by flow cytometry (four independent replicates of data represented by A; 
replicates are shown with different colours). Emulsification appears able to disrupt clumps until late log phase (~day 
8), when both the ratio of clumps to single cells and size (approximated by mean FSC) of clumps rise rapidly. Line 









.CC-BY 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint (whichthis version posted May 2, 2021. ; https://doi.org/10.1101/2021.05.01.442251doi: bioRxiv preprint 





Three mid-log phase M. smegmatis cultures grown in 0.05% Tween80 7H9 with continuous agitation at 150 rpm
biological replicates shown in blue, green and red), processed three ways. Control sample: 10-1 dilution in 0.
Tween80 PBS, no physical disruption. Centrifuge sample: 10ml + 5ml 0.1% Tween80 PBS; spun in 15ml centrif
tubes at 120 x g for 8 minutes with no brake. Emulsified sample: 10-1 dilution in 0.1% Tween80 PBS, 12x nee
emulsified. Supernatant used for counts, as per ref 42 main manuscript. All samples heat-killed and stained with SYB
gold prior to flow cytometry on BD Accuri-C6, with thresholding on SSC and FL1. Data are for three techn
replicates of each culture. 
A. Qualitatively, the FSC by SSC flow plots were similar for centrifuge method and control, compared to the need
emulsified sample where the cell-clump population (P2) was not evident.  
B. The ratio of clumps to single cells (p2:p1) was the same in the control and centrifuge preparations, but was m
lower (and with less variation across replicates) with emulsification. Apparent cell counts were lower w
centrifugation (owing to loss of cells in pellet) and higher with emulsification (owing to disruption of clumps). Th
independent culture replicates (read, blue, and green; each processed 3 times in each condition for technical replicat
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Figure 7. Bacillary population dynamics during standard growth in culture 
 
Four independent M. bovis BCG cultures (replicates i to iv), grown in 50ml 0.15% v/v Tween80 7H9, 500ml tissueculture 
flasks at 150 rpm agitation, were serially quantified by CFU and FCM counts (method outlined in figure 6) between 2 and 15 
days after inoculation into pre-warmed broth from a log phase starter culture. (A) Using the heat-killed SYBR-gold stained 
(HK) cell count as total cell denominator, the proportion of bacilli which were Calcein-AM positive (CA+), colony-forming 
(CFU), and permeable to SYBR-gold without heat-killing (SG+) are shown over time post inoculation (B-D); each replicate 
is plotted using a different colour; LOESS line-of-best-fit and 95% CI shown for the observations aggregated across 
replicates. Linear correlation between log CA+ and log CFU counts was strong (E), but with a dependency on phase of 
growth (time in days from inoculation shown by colour;  non-constant variance (NCV) test for heteroscedasticity, p=0.03, 
dashed lines are +/- 1 SD of residual variation). Rate of population growth is defined as instantaneous rate of change in total 
cell count (slope of the tangent to the curve at a given timepoint; i.e., first derivative of the growth curve). Rate of total 
population growth was regressed on proportion of bacilli able to form colonies, or on proportion CA+ (F), at any given 
timepoint, with each replicate (i to iv, again shown by colour) allowed to differ by intercept but not slope.
.CC-BY 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint (whichthis version posted May 2, 2021. ; https://doi.org/10.1101/2021.05.01.442251doi: bioRxiv preprint 
Figure 8. Raw FMC plots of HK, CA+, and SG+ events for selected antimicrobial conditions and timepoints. 
 
Raw FMC data from one of three independent replicates. SYBR-gold stained heat-killed (HK) samples (A, left), Calcein-AM stained live samples (B, middle), an
gold stained live samples (C, right), by antimicrobial condition (rows) and time-point (hours) post introduction of antimicrobials (columns). Antimicrobial indica
prefix (E, ethambutol; H, isoniazid; K, kanamycin; R, rifampicin) and concentration in multiples of MIC99 by suffix letter (e.g., R4 = rifampicin at 4x MIC). FCM
each plot are coloured by K-means clustering on all light-scatter and fluorescence dimensions – an unsupervised classification (machine learning) algorithm used
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 events in 
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Figure 9. Time-kill curves generated through FCM defined cell populations and CFU counts 
 
Data from three replicates. Counts (left panel) and proportions (right panel) by cell population [CA+ = Calcein-AM-stained in live samples; CFU = colony forming units; 
SG+ = SYBR-gold-stained in live samples; HK = SYBR-gold-stained in heat-killed samples] over time by antimicrobial condition. Antimicrobial indicated by letter in rows 
(E, ethambutol; H, isoniazid; K, kanamycin; R, rifampicin; CTRL, antimicrobial-free [“Nil Abx”] broth) and concentration in multiples of MIC in columns. Non-parametric 
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Figure 10. Emax models applied to time-kill data from FCM defined cell population and CFU counts 
 
 
The time-kill data in figure 9 were modelled using a linear mixed-effects model to extract an estimate of mono-
exponential elimination rate for each antimicrobial condition as a summary pharmacodynamic (PD) measure for 
each FCM defined cell population and CFU counts. Antimicrobial effects extracted from these models were related 
to drug concentration for each antimicrobial using a standard sigmoid Emax PK/PD model, shown here for each 
antimicrobial (columns) and each cell population (rows). 
* A sigmoidal Emax model could not be fit for rifampicin %SG+ growth rate data due to non-convergence; the fit 
shown is from a model excluding the outlier data point at concentration 0.005 mg/ml (-5.3 on log scale). When this 
data point (indicated in grey) was excluded, the model converged.  
  
.CC-BY 4.0 International licenseavailable under a
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprint (whichthis version posted May 2, 2021. ; https://doi.org/10.1101/2021.05.01.442251doi: bioRxiv preprint 
 
Figure 11. Distinct pharmacodynamics of SYBR-gold-positive sub-populations  
A. FCM plot for ethambutol-treated (4x MIC, 48 hours), SYBR-gold stained live bacilli. Two discrete sub-populations ar
visible, separated by approximately two-fold difference in fluorescence. These sub-populations were visible in most 
ethambutol- or isoniazid-treated cultures, but not readily visible in rifampicin or kanamycin FCM plots (figure 8). B. Aft
membrane permeabilization at room temperature, these distinct sub-populations are visible under all conditions including
antimicrobial-free control. C. Clustering algorithm (Gaussian mixture model) used to label bacilli as P1 (lower SG 
fluorescence) or P2 (higher SG fluorescence). D. P1 and P2 bacilli sorted for downstream microscopy show different 
morphologies. A random selection of bacilli images from sorted P1 and P2 sub-populations were measured along their 
longitudinal axis using ImageJ to assess length and fluorescence profile (two examples shown). P2 bacilli were longer th
bacilli (mean 4.0µm versus 2.5µm) and contained approximately double the number of fluorescent 'peaks' (mean 6.1 vers
peaks defined by local maxima in a LOESS smoothing function applied to the fluorescence profile plots). E. The ratio of
bacillary counts was dependent on antimicrobial: isoniazid and ethambutol exposure caused a relative rise in P2 bacilli 
compared to control, but the same effect was not seen for rifampicin or kanamycin. For the rifampicin plus isoniazid (Rif
combination treatment, the P2:P1 ratio matched the ratio obtained for rifampicin monotherapy, rather than isoniazid. All 
values were determined from a linear regression of P2:P1 ratio on antimicrobial category, with the antimicrobial-free con
reference category. F. Non-parametric Loess regression fitting P2:P1 ratio to log2 concentration (black line with shaded 
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